| Not Yet Recruiting | A Phase II Clinical Trial of SHR-1826 for Non-Small Cell Lung Cancer Non-Small Cell Lung Cancer | Phase 2 | 2026-04-01 |
| Recruiting | A Study of SHR-A2102 Versus Investigator's Choice of Chemotherapy in Patients With Platinum-based Chemotherapy Recurrent Cervical Cancer, Metastatic Cervical Cancer | Phase 3 | 2026-03-30 |
| Recruiting | A Study of SHR-A1904 in Previous Systemic Treatment Failed Biliary Tract Cancer Biliary Tract Cancer | Phase 2 | 2026-03-25 |
| Recruiting | A Phase I Study of Single Subcutaneous Dose of SHR-1894 in Healthy Subjects Dermatitis | Phase 1 | 2026-03-16 |
| Not Yet Recruiting | A Randomized, Double-blind, Placebo-controlled, Multicenter Phase II/III Clinical Study of Adebrelimab in Comb Locally Advanced Resectable Rectal Cancer | Phase 2 / Phase 3 | 2026-03-01 |
| Not Yet Recruiting | A Study of Intravesical SHR-1501 Combination With BCG Versus Investigator-selected Chemotherapy in Subjects Wi NMIBC | Phase 3 | 2026-03-01 |
| Not Yet Recruiting | A Study of SHR-2524 Plus Bevacizumab in the First-line Treatment of Advanced Hepatocellular Carcinoma Advanced Unresectable Hepatocellular Carcinoma | Phase 1 | 2026-03-01 |
| Recruiting | A IB/II Phase Clinical Study on the Safety, Tolerability, and Efficacy of SHR-9839(sc) in Combination Anti-tum Solid Tumor | Phase 1 / Phase 2 | 2026-02-27 |
| Recruiting | A Trial of SHR-A2102 With Adebrelimab in Locally Advanced or Metastatic Urothelial Carcinoma Locally Advanced or Metastatic Urothelial Carcinoma | Phase 3 | 2026-02-12 |
| Recruiting | A Phase III Study of SHR-8068 in Combination With Adebrelimab and Platinum-Containing Chemotherapy Versus Durv Advanced Biliary Tract Cancer | Phase 3 | 2026-01-21 |
| Recruiting | Phase Ib/II Clinical Study of SHR-8068 Combined With Adebrelimab and Other Anti-tumor Drugs in the Treatment o Advanced Renal Cell Carcinoma | Phase 1 / Phase 2 | 2026-01-06 |
| Recruiting | A Clinical Study of SHR-A1811(sc) Subcutaneous Injection in Patients With Solid Tumor Solid Tumor | Phase 1 | 2025-12-23 |
| Not Yet Recruiting | A Study of SHR-4375 Injection in Combination With Other Antitumor Therapies in Patients With Solid Tumors Advanced Solid Tumor | Phase 1 / Phase 2 | 2025-12-01 |
| Not Yet Recruiting | A Phase I/II Clinical Study of SHR-4298 Injection in Patients With Malignant Solid Tumors Malignant Solid Tumors | Phase 1 / Phase 2 | 2025-11-01 |
| Recruiting | A Study of SHR-A2009 Combined With Aumolertinib Versus Aumolertinib for First-line Treatment in EGFR-mutated, Non-small Cell Lung Cancer | Phase 3 | 2025-10-30 |
| Recruiting | Phase III Study of SHR-8068 Combined With Adebrelimab and Chemotherapy Versus Tislelizumab Combined With Chemo Advanced or Metastatic Non-small Cell Lung Cancer | Phase 3 | 2025-10-22 |
| Recruiting | A Trial of Adebrelimab Plus (SHR-A1811/SHR-A1904 With Chemotherapy) or SHR-8068 as Treatment for Gastric/GEJ C Gastric Cancer, Gastroesophageal-junction Cancer | Phase 2 | 2025-08-28 |
| Recruiting | A Trial of SHR-7782 for Treatment of Advanced Malignant Tumors Advanced Malignancy | Phase 1 | 2025-08-28 |
| Recruiting | A Clinical Trial of SHR-A1811 in the Treatment of Triple-negative Breast Cancer PD-L1-positive Locally Recurrent Unresectable or Metastatic Triple-negative Breast Cancer | Phase 3 | 2025-08-20 |
| Recruiting | A Phase III Study of SHR-A1811 in Combination With Chemotherapy and Adebrelimab in Previously Untreated Patien Patients With Unresectable Locally Advanced or Metastatic Untreated Gastric or Gastroesophageal Junction Adenocarcinoma | Phase 3 | 2025-08-18 |
| Recruiting | A Clinical Study of SHR-4506 Injection in Patients With Malignant Tumors Malignant Tumors of Adults | Phase 1 | 2025-07-22 |
| Recruiting | A Phase II Study of SHR-8068 Injection in Combination With Anti-tumor Therapies in Colorectal Cancer Colorectal Cancer | Phase 2 | 2025-07-22 |
| Recruiting | A Trial of SHR-A2102 With Adebrelimab With or Without Other Anti-tumor Therapies in Recurrent/MetastaticHead a Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma | Phase 1 / Phase 2 | 2025-07-11 |
| Recruiting | A Trial of SHR-4849 Combined With Other Antitumor Drugs in Patients With Malignant Solid Tumors Malignant Solid Tumors | Phase 2 | 2025-07-08 |
| Recruiting | A Trial of SHR-2017 Injection in Patients With Bone Metastases From Solid Tumors For Prevention of Bone Events in Patients With Bone Metastases From Solid Tumors | Phase 2 | 2025-06-24 |
| Recruiting | Phase I Clinical Study of SHR-1316 (SC) Combined With Carboplatin and Etoposide as First-line Treatment for Ex Widespread Small Cell Lung Cancer | Phase 1 | 2025-06-16 |
| Recruiting | A Trial of SHR-1314 Injection in Adult Patients With Active Non-radiographic Axial Spondyloarthritis Active Non-radiographic Axial Spondyloarthritis | Phase 3 | 2025-04-29 |
| Recruiting | Clinical Study on the Treatment of MIBC Patients With SHR-A2102 Injection Combined With Adebrelimab (SHR-1316) Muscular Invasive Bladder Cancer (MIBC) | Phase 2 / Phase 3 | 2025-04-25 |
| Recruiting | SHR-A1811 Combination Regimen for the Treatment of Recurrent or Metastatic Cervical Cancer Recurrent or Metastatic Cervical Cancer | Phase 1 / Phase 2 | 2025-04-25 |
| Recruiting | A Phase 3 Clinical Study of SHR-A1912 Combined With R-GemOx Versus R-GemOx in Diffuse Large B-cell Lymphoma Diffuse Large B-cell Lymphoma | Phase 3 | 2025-04-24 |
| Recruiting | A Trial of SHR-3792 Injection in Patients With Advanced Solid Tumors Advanced Solid Tumors | Phase 1 | 2025-04-02 |
| Recruiting | A Clinical Study of SHR-A1811 Combined With Chemotherapy for Platinum Sensitive Recurrent Ovarian Cancer Ovarian Cancer | Phase 1 / Phase 2 | 2025-03-18 |
| Recruiting | A Phase II Clinical Study of SHR-1826 for Injection in Patients With NSCLC NSCLC | Phase 2 | 2025-03-07 |
| Recruiting | A Clinical Study of SHR-A1811 in the Treatment of HER2-positive Locally Advanced or Metastatic Biliary Tract C HER2-positive Locally Advanced or Metastatic Biliary Tract Cancer | Phase 2 | 2025-02-26 |
| Recruiting | A Study of SHR-1826 for Injection in Combination With Other Antitumor Therapies in Subjects With Solid Tumors Advanced Solid Tumors | Phase 1 / Phase 2 | 2025-02-18 |
| Recruiting | A Study of SHR-1826 for Injection in Combination With Other Antitumor Therapies in Subjects With NSCLC Non-small Cell Lung Cancer (NSCLC) | Phase 1 / Phase 2 | 2025-02-18 |
| Not Yet Recruiting | Phase IV Study: Vunakizumab Efficacy and Safety in Moderate-to-severe Plaque Psoriasis Moderate to Severe Plaque Psoriasis | Phase 4 | 2025-02-01 |
| Not Yet Recruiting | The Efficacy and Safety of SHR-1314 in the Treatment of Pediatric Patients of Age 6 to <18 Years With Moderate Children and Adolescents Aged 6 to 18 With Moderate-to-Severe Plaque Psoriasis | Phase 3 | 2025-02-01 |
| Recruiting | A Phase I/II Clinical Study of SHR-1681 for Injection in Patients With Advanced Solid Tumors Malignant Solid Tumors | Phase 1 / Phase 2 | 2025-01-21 |
| Recruiting | A Study of SHR-4375 in Subjects With Solid Tumors Solid Tumors | Phase 1 / Phase 2 | 2025-01-09 |
| Recruiting | A Clinical Study of SHR-3276 for Injection in Patients With Advanced Malignant Tumors Advanced Solid Tumors | Phase 1 / Phase 2 | 2024-12-10 |
| Active Not Recruiting | A Study of SHR-A2009 Versus Platinum-based Chemotherapy in EGFR-mutated, Advanced or Metastatic NSCLC Non-small Cell Lung Cancer | Phase 3 | 2024-11-29 |
| Recruiting | A Study of SHR-3821 Injection in Subjects With Advanced Solid Tumors Advanced Solid Tumors | Phase 1 | 2024-11-13 |
| Recruiting | A Study of the Efficacy and Safety of SHR-1314 for Adult Active Psoriatic Arthritis Psoriatic Arthritis | Phase 3 | 2024-11-04 |
| Recruiting | Study of SHR-8068 Combined With Adebrelimab and Bevacizumab Versus Sintilimab Combined With Bevacizumab for th Advanced Hepatocellular Carcinoma | Phase 3 | 2024-10-28 |
| Withdrawn | Clinical Study of SHR-A1921 Combined With Adebrelimab and SHR-8068 With or Without Carboplatin in the Treatmen Advanced Non-small Cell Lung Cancer | Phase 1 / Phase 2 | 2024-10-10 |
| Not Yet Recruiting | Neoadjuvant SHR-A1811 Plus Adebrelimab in HR Negative/Low & HER2 Low Breast Cancer Patients Untreated Early-stage or Locally Advanced Breast Cancer | Phase 2 | 2024-09-20 |
| Recruiting | A Clinical Study of SHR-9539 in Patients With Multiple Myeloma Multiple Myeloma | Phase 1 | 2024-08-07 |
| Recruiting | Adebrelimab With or Without SHR-8068 in Combination With Cisplatin Plus Gemcitabine as First-line Treatment in Biliary Tract Cancer | Phase 2 | 2024-07-01 |
| Recruiting | A Trial of SHR-4849 in Advanced Solid Tumors Advanced Solid Tumors | Phase 1 | 2024-06-26 |
| Completed | The Clinical Study of SHR-7631 for Injection in Patients With Advanced Solid Tumors Advanced Solid Tumors | Phase 1 | 2024-05-24 |
| Completed | PK/PD Study of SHR-2017 Injection in Patients With Bone Metastases Patients With Bone Metastases | Phase 1 | 2024-05-20 |
| Recruiting | SHR-A1921 for Injection in Patients With Platinum-Resistant Recurrent Epithelial Ovarian Cancer Ovarian Cancer | Phase 3 | 2024-05-10 |
| Active Not Recruiting | Study of SHR-8068 Combined With Adebrelimab and Platinum-containing Chemotherapy in the Treatment of Advanced Advanced Gastric Adenocarcinoma and Esophageal Squamous Cell Carcinoma | Phase 2 | 2024-03-11 |
| Active Not Recruiting | Injection of SHR-A1811 Versus Physician Choiced Treatment in Patients With Advanced Colorectal Cancer Who Had Advanced Colorectal Cancer | Phase 3 | 2024-03-01 |
| Not Yet Recruiting | A Study of SHR-A1921 With or Without Carboplatin in Subjects With Ovarian Cancer Ovarian Cancer | Phase 2 / Phase 3 | 2024-02-15 |
| Recruiting | An Open Phase I Clinical Trial of SHR-1826 for Injection in Patients With Advanced Solid Tumors Advanced Solid Tumors | Phase 1 | 2023-12-25 |
| Completed | A Clinical Study to Compare the Safety and Pharmacokinetics of SHR-1314 Injection in Healthy Subjects at Diffe Moderate-to-Severe Plaque Psoriasis | Phase 1 | 2023-12-24 |
| Not Yet Recruiting | Phase I Study of SHR-2022 Injection in the Treatment of Patients With Advanced Malignant Tumors Advanced Malignant Cancer | Phase 1 | 2023-12-01 |
| Unknown | Phase I Clinical Study of SHR-5495 in the Treatment of Patients With Advanced Malignant Tumors Advanced Malignant Tumor | Phase 1 | 2023-10-25 |
| Unknown | A Phase IB/II Clinical Study of SHR-A2009 for Injection in Combination With Other Antitumor Therapies in Patie Advanced Solid Tumors | Phase 1 / Phase 2 | 2023-10-01 |
| Unknown | A Study of SHR-A1811 Combined With Capecitabine in Treatment of Unresectable or Metastatic Breast Cancer With Breast Cancer | Phase 1 / Phase 2 | 2023-07-25 |
| Unknown | Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SHR-2017 Injection in Po Osteoporosis | Phase 1 | 2023-07-04 |
| Recruiting | A Study of SHR-4602 in Subjects With Advanced Malignant Solid Tumors Advanced Solid Tumor | Phase 1 | 2023-04-18 |
| Recruiting | Ph1b/2 Study of the Safety and Efficacy of SHR-A1811 Combinations in Advanced HER2 Expression Gastric Cancer HER2 Expression Gastric Cancer/Gastroesophageal Junction Adenocarcinoma | Phase 2 | 2023-03-14 |
| Active Not Recruiting | Study of SHR-A1921 in Combination With Other Anti-cancer Agents in Patients With Advanced Solid Tumors Advanced Solid Tumor | Phase 1 / Phase 2 | 2022-12-30 |
| Not Yet Recruiting | Phase Ib/II Study of Almonertinib Combined With SHR-1701 in the Treatment of Relapsed or Advanced Non-small Ce Relapsed or Advanced Non-small Cell Lung Cancer | Phase 1 / Phase 2 | 2022-10-01 |
| Terminated | Efficacy and Safety of SHR-1314 by Subcutaneous Injection in Active Moderate to Severe Graves' Orbitopathy Pat Active Moderate to Severe Graves' Orbitopathy | Phase 2 | 2022-09-13 |
| Recruiting | Phase Ib/II Study of SHR-8068 Injection in the Treatment of Advanced Non-small Cell Lung Cancer Advanced Non-small Cell Lung Cancer | Phase 1 / Phase 2 | 2022-08-15 |
| Recruiting | Study of SHR-8068 Combined With Adebrelimab and Bevacizumab in the Treatment of Advanced Hepatocellular Carcin Advanced Hepatocellular Carcinoma | Phase 1 / Phase 2 | 2022-08-02 |
| Completed | The Clinical Study of SHR-A2009 for Injection in Patients With Advanced Solid Tumors Advanced Solid Tumor | Phase 1 | 2022-07-21 |
| Recruiting | SHR-1701 in Combination With Chemotherapy and Radiotherapy in Locally Advanced Rectal Cancer Locally Advanced Rectal Cancer | Phase 2 | 2022-07-05 |
| Unknown | A Trial of the Combination of SHR-A1811 and Fluzoparib in HER2-Expressing Cancers Advanced Solid Tumors | Phase 2 | 2022-06-09 |
| Terminated | A Study of SHR-1701 Plus Platinum-containing Chemotherapy With or Without BP102 (Bevacizumab) as First-line Tr Cervical Cancer | Phase 3 | 2022-02-26 |
| Unknown | A Trial of SHR-2002 Injection or Combined With Other Anti-cancer Medication in Advanced Malignant Tumors of Pa Advanced Malignant Tumors | Phase 1 | 2022-02-22 |
| Unknown | A Clinical Study of the Safety and Tolerability of SHR-1901 in Subjects With Advanced Malignant Tumors Advanced Malignant Tumors | Phase 1 | 2022-02-10 |
| Terminated | Clinical Study of SHR-1701 Plus Chemotherapy as Perioperative Treatment in Subjects With Gastric Cancer Perioperative Treatment in Subjects With Locally Advanced Resectable Gastric Cancer or Gastroesophageal Junction Cancer | Phase 2 / Phase 3 | 2022-01-26 |
| Terminated | A Study of Camrelizumab in Combination With Chemotherapy Regimen Comparative Chemotherapy Regimen for Metastat Triple Negative Breast Cancer | Phase 3 | 2022-01-17 |
| Unknown | A Phase I Clinical Study of SHR-A2009 for Injection in Patients With Advanced Solid Tumors Advanced Solid Tumors | Phase 1 | 2022-01-04 |
| Unknown | A Study of SHR-A1921 for Injection in Subjects With Advanced Solid Tumours Advanced Solid Tumours | Phase 1 | 2021-12-31 |
| Unknown | A Study of SHR-1701 Plus Bevacizumab and Chemotherapy in Non-Small-Cell-Lung-Cancer Advanced or Metastatic Non-squamous Non-small-cell Lung Cancer | Phase 3 | 2021-12-30 |
| Active Not Recruiting | A Trial of SHR1701 Plus Chemotherapy in Patients With Gastric or Gastroesophageal Cancer Gastric or Gastroesophageal Junction Cancer | Phase 3 | 2021-12-06 |
| Completed | Study of the Effectiveness and Safety of SHR-1314 for Psoriatic Arthritis Psoriatic Arthritis | Phase 2 | 2021-10-22 |
| Unknown | Study of SHR-1701 Plus BP102 in Subjects With Selected Solid Tumors Advanced or Metastatic Non-squamous Non-small Cell Lung Cancer | Phase 2 | 2021-08-30 |
| Unknown | A Phase II Study to Evaluate the Efficacy and Safety of SHR-1314 in Lupus Nephritis Lupus Nephritis | Phase 2 | 2021-06-28 |
| Terminated | A Clinical Studyf of SHR-1701 or Placebo in Combination With BP102 and XELOX in the First-line Treatment of mC Metastatic Colorectal Cancer (mCRC) | Phase 2 / Phase 3 | 2021-06-22 |
| Completed | Efficacy and Safety of SHR-1314 in Patients With Active Ankylosing Spondylitis Ankylosing Spondylitis | Phase 2 / Phase 3 | 2021-06-09 |
| Completed | Trial of SHR-1701 Plus BP102 in Subjects With Selected Solid Tumors Advanced Solid Tumors | Phase 1 / Phase 2 | 2021-06-01 |